Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-071897

Chief Medical Officer gave up 3,976 shares (to pay taxes)

  • Chief Medical Officer acquired 7,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-06-05 Option exercise +7,813 144,087 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-06-05 Shares withheld for taxes −3,976 $4.23 $16,818 140,111 D
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-06-05 Option exercise · Restricted Stock Units −7,813 54,691 D
Loading xslF345X06/tm2617137-3_4seq1.xml…